Barlev D, Eisen D B, Alikhan A
Department of Dermatology, University of Cincinnati, OH, USA.
Department of Dermatology, University of California Davis, CA, USA.
Skin Therapy Lett. 2015 Jul-Aug;20(4):1-8.
Hidradenitis suppurativa (HS) is a chronic disease of the follicular unit that often leads to marked impairment of quality of life and usually affects the axillary, perineum and inframammary regions resulting in tender subcutaneous nodules, abscesses, fibrosis and sinus tract formation. New updates on HS underscores the role of various genes as well as the innate and adaptive immune response in its pathogenesis. Although every patient requires an individualized approach to treatment, topical therapy and antibiotics are mainly used for mild to moderate disease, whereas various systemic immune modulators and/or surgical approaches play a pivotal role in moderate to severe disease. New treatments using various immune modulators, laser modalities and other novel agents provide clinicians with better ways of managing HS.
化脓性汗腺炎(HS)是一种毛囊单位的慢性疾病,常导致生活质量显著受损,通常累及腋窝、会阴和乳房下区域,导致皮下出现压痛性结节、脓肿、纤维化和窦道形成。HS的新进展强调了多种基因以及先天性和适应性免疫反应在其发病机制中的作用。尽管每位患者都需要个体化的治疗方法,但局部治疗和抗生素主要用于轻至中度疾病,而各种全身免疫调节剂和/或手术方法在中至重度疾病中起关键作用。使用各种免疫调节剂、激光治疗方式和其他新型药物的新疗法为临床医生提供了更好的HS治疗方法。